Vascular permeability assessment measures blood vessel wall integrity predicting extravasation risk and drug delivery. Fluorescein leakage quantitates endothelial junction disruption. Albumin extravasation indicates increased permeability. Inflammatory mediators increase permeability transiently. Reversibility assessment determines permanence of changes.
Formulation strategies exploit enhanced permeability. Targeting approaches deliver drugs selectively to leaky vasculature. Regulatory submissions address permeability implications. Post-approval monitoring detects unexpected permeability changes. Clinical outcomes correlate with permeability status.
General Biopharmaceutical Concepts
Vascular Permeability Assessment
Vascular permeability assessment evaluates the movement of fluids and molecules across blood vessel walls to understand disease processes and therapeutic effects.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →